Summary
Aristo Bio-Tech and Lifescience share holding pattern reports the following shareholding: Aristo Bio-Tech and Lifescience Total Promoters is at 73.42%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 26.58%. This breakdown provides a quick snapshot of ownership distribution for Aristo Bio-Tech and Lifescience share holding pattern in 2026-27.
Aristo Bio-Tech and Lifescience FAQs
As of 06-2026, the promoter shareholding in Aristo Bio-Tech and Lifescience stands at 73.42% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Aristo Bio-Tech and Lifescience is 0% and 0% respectively.
The retail shareholding of the Aristo Bio-Tech and Lifescience is 26.58%.
Changes in shareholding patterns of Aristo Bio-Tech and Lifescience can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Aristo Bio-Tech and Lifescience are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Aristo Bio-Tech and Lifescience Associated Pages
- Aristo Bio-Tech and Lifescience Share Price
- Aristo Bio-Tech and Lifescience Share Price chart
- Aristo Bio-Tech and Lifescience Fundamental Analysis
- Aristo Bio-Tech and Lifescience Technical Analysis
- Aristo Bio-Tech and Lifescience Peer Comparison
- Aristo Bio-Tech and Lifescience Share Price History
- Aristo Bio-Tech and Lifescience Dividend
- Aristo Bio-Tech and Lifescience Board of Directors
